Advisory Panel Backs Approval Of Auxilium's Xiaflex, Wants Post-Market Data
This article was originally published in The Pink Sheet Daily
Executive Summary
Members agree 12-0 that drug is approvable, offer opinion on who should dispense and the amount of training needed.
You may also be interested in...
Financings Of The Fortnight: IPOs Make A Return In Talecris And Omeros Deals
Money continued to flow to big and small biotechs, including nearly a dozen PIPEs or registered direct offerings.
Financings Of The Fortnight: IPOs Make A Return In Talecris And Omeros Deals
Money continued to flow to big and small biotechs, including nearly a dozen PIPEs or registered direct offerings.
Auxilium Xiaflex's Advisory Committee To Focus On Physician Expertise, Training
Majority of clinical trial investigators were hand or orthopedic surgeons and FDA asks if this level of expertise is needed to safely use the biologic.